SCHEMBL4695833

SCHEMBL4695833

ONOCc1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.53
RAB9A P51151 4/20 0.53
TSHR P16473 2/20 0.52
IDO1 P14902 2/20 0.48
THRB P10828 1/20 0.48
HRAS P01112 1/20 0.47
AGXT P21549 1/20 0.46
ALDH1A1 P00352 3/20 0.45
SLC6A2 P23975 2/20 0.45
SLC6A3 Q01959 2/20 0.45
LMNA P02545 1/20 0.45
CYP1A2 P05177 1/20 0.45
PTGS1 P23219 1/20 0.45
CYP2C19 P33261 1/20 0.45
PTGS2 P35354 1/20 0.45
HIF1A Q16665 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45
MAPK1 P28482 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
CA12 O43570 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3588939 0.98 NPC1 (0.52) NPC1RAB9ATSHRIDO1THRB
SCHEMBL538293 0.79 TSHR (0.57) NPC1RAB9ATSHRIDO1HRAS
SCHEMBL23489775 0.78 NPC1 (0.40) NPC1RAB9ATSHRIDO1THRB
Hydrochloric Acid SCHEMBL11220071 0.77 TSHR (0.55) NPC1RAB9ATSHRIDO1HRAS
SCHEMBL6509893 0.76 NPC1 (0.65) NPC1RAB9AALDH1A1SLC6A2SLC6A3
SCHEMBL9278982 0.76 IDO1 (0.60) IDO1AGXT
SCHEMBL8863647 0.75 IDO1 (0.54) NPC1RAB9ATSHRIDO1HRAS
SCHEMBL4744780 0.75 TSHR (0.52) NPC1RAB9ATSHRIDO1HRAS
SCHEMBL28510963 0.75 TSHR (0.52) NPC1RAB9ATSHRIDO1HRAS
SCHEMBL4589000 0.75 TSHR (0.52) NPC1RAB9ATSHRIDO1HRAS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008099368-A1 MACROLIDE DERIVATIVES AS ANTIBACTERIAL AGENTS RANBAXY LABORATORIES LIMITED (IN) 2008-08-21 WO claimed
CN-100593401-C Combination of an aromatase inhibitor with a bisphosphonate NOVARTIS AG 2010-03-10 CN disclosed
EP-1680421-B1 USE OF TRICYCLIC COMPOUNDS AS GLYCINE TRANSPORT INHIBITORS SANOFI AVENTIS (FR) 2008-02-13 EP disclosed
EP-1680421-A2 USE OF TRICYCLIC COMPOUNDS AS GLYCINE TRANSPORT INHIBITORS Sanofi-Aventis (FR) 2006-07-19 EP disclosed
CN-1671371-A Combination of an aromatase inhibitor with a bisphosphonate NOVARTIS AG (CH) 2005-09-21 CN disclosed
WO-2005037783-A2 USE OF TRICYCLIC COMPOUNDS AS GLYCINE TRANSPORT INHIBITORS SANOFI-AVENTIS (FR) 2005-04-28 WO disclosed
CN-1089086-C Luminandide medicine MILLS RANDELL L (US) 2002-08-14 CN disclosed
CN-1047075-A Luminandide medicine MILLS RANDELL L (US) 1990-11-21 CN disclosed
US-4738803-A ENZYME INHIBITORS ROQUES BERNARD (FR) 1988-04-19 US disclosed